We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
-8.89%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$513M
AUM Growth
-$457M
Cap. Flow
-$450M
Cap. Flow %
-87.61%
Top 10 Hldgs %
17.54%
Holding
218
New
19
Increased
57
Reduced
54
Closed
46

Sector Composition

Rank Sector Weight
1 Healthcare 23.77%
2 Technology 17.55%
3 Consumer Discretionary 8.35%
4 Industrials 6.82%
5 Consumer Staples 5.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVLR
51
DELISTED
Avalara, Inc.
AVLR
$3.24M 0.63%
43,463
-2,939
-6% -$240K
PODD icon
52
Insulet
PODD
$9.79B
$3.08M 0.6%
+18,596
New +$3.4M
SMAR
53
DELISTED
Smartsheet Inc.
SMAR
$2.99M 0.58%
71,966
-22,521
-24% -$1.02M
APTV icon
54
Aptiv
APTV
$10.3B
$2.96M 0.58%
60,220
-3,970
-6% -$311K
GH icon
55
Guardant Health
GH
$22.6B
$2.96M 0.58%
42,596
+358
+0.8% +$27.5K
QURE icon
56
uniQure
QURE
$3.22B
$2.91M 0.57%
61,402
-39,252
-39% -$2.26M
TRNO icon
57
Terreno Realty
TRNO
$7.49B
$2.88M 0.56%
55,578
+14,975
+37% +$826K
MYOK
58
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$2.83M 0.55%
60,308
-2,326
-4% -$149K
RETA
59
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$2.8M 0.54%
19,388
-17,723
-48% -$3.42M
COLD icon
60
Americold
COLD
$4.27B
$2.75M 0.54%
80,832
-5,939
-7% -$199K
ESPR
61
DELISTED
Esperion Therapeutics
ESPR
$2.71M 0.53%
86,118
+17,548
+26% +$926K
TWLO icon
62
Twilio
TWLO
$36.6B
$2.71M 0.53%
30,290
+18,341
+153% +$2.01M
CRWD icon
63
CrowdStrike
CRWD
$218B
$2.53M 0.49%
+181,756
New +$2.57M
MANT
64
DELISTED
Mantech International Corp
MANT
$2.43M 0.47%
33,440
+1,573
+5% +$123K
NBIX icon
65
Neurocrine Biosciences
NBIX
$16.6B
$2.4M 0.47%
27,668
-1,742
-6% -$170K
CCI.PRA
66
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
0
DHR icon
67
Danaher
DHR
$144B
$2.26M 0.44%
18,382
-8,925
-33% -$1.2M
AAPL icon
68
Apple
AAPL
$4.57T
$2.22M 0.43%
34,976
-16,756
-32% -$1.23M
BMRN icon
69
BioMarin Pharmaceuticals
BMRN
$12.4B
$2.22M 0.43%
+26,302
New +$2.27M
CDLX icon
70
Cardlytics
CDLX
$21.5M
$2.21M 0.43%
6,330
-679
-10% -$481K
FISV
71
Fiserv Inc
FISV
$27.9B
$2.2M 0.43%
23,173
-1,238
-5% -$138K
ELAT
72
DELISTED
Elanco Animal Health Incorporated 5.00% Tangible Equity Units
ELAT
0
AVTR icon
73
Avantor
AVTR
$9.19B
$2.15M 0.42%
172,284
-11,883
-6% -$191K
SKYW icon
74
Skywest
SKYW
$4.34B
$2.14M 0.42%
81,673
+12,040
+17% +$588K
CRM icon
75
Salesforce
CRM
$158B
$2.13M 0.42%
14,828
+7,405
+100% +$1.27M

Similar funds

Nicholas Investment Partners's Q1 2020 Portfolio in Review

As of Q1 2020, Nicholas Investment Partners held 218 positions worth $513M, down 47% from $971M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Nicholas Investment Partners withdrew a net $450M in Q1 2020, closing 46 positions and reducing 54 holdings. Its most notable exit was Las Vegas Sands, an estimated $69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Nicholas Investment Partners opened a new position in Deciphera Pharmaceuticals, Inc. Common Stock worth $4.05M.

  • Nicholas Investment Partners's largest Q1 2020 buy was Deciphera Pharmaceuticals, Inc. Common Stock: 98,299 shares worth $4.05M.
  • Nicholas Investment Partners added most to Freshpet in Q1 2020, an estimated $6.06M increase.
  • Nicholas Investment Partners's biggest Q1 2020 reduction was Kontoor Brands, cutting an estimated $17.6M.
  • Nicholas Investment Partners fully exited Las Vegas Sands in Q1 2020, selling an estimated $69M.
  • Nicholas Investment Partners's ten largest holdings make up 18% of its $513M portfolio in Q1 2020.
  • Nicholas Investment Partners opened 19 new positions and closed 46 in Q1 2020.
  • Nicholas Investment Partners's portfolio value fell 47% quarter-over-quarter to $513M.

Based on Nicholas Investment Partners's 13F filing for Q1 2020, filed 13 May 2020.